<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38031001</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2466</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Nov</Month><Day>29</Day></PubDate></JournalIssue><Title>BMC pulmonary medicine</Title><ISOAbbreviation>BMC Pulm Med</ISOAbbreviation></Journal><ArticleTitle>Incidence and causative agent distribution of viral-induced paediatric asthma exacerbations under strict infection control measures: a single-centre retrospective study in Japan.</ArticleTitle><Pagination><StartPage>480</StartPage><MedlinePgn>480</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">480</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12890-023-02779-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The prevalence of respiratory viruses in children changed under strict infection control measures during the coronavirus disease 2019 (COVID-19) outbreak. In this study, we investigated the frequency of viral detection in the nasopharynx of paediatric patients with asthma exacerbations requiring hospitalization during the COVID-19 pandemic, as well as the distribution of causative viruses.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We included paediatric patients admitted for asthma exacerbations between November 2020 and December 2022 at a single centre in Kobe, Japan. Demographic, clinical, and laboratory data were collected from their medical records and using additional questionnaires. All patients enrolled in this study met the diagnostic criteria for asthma exacerbations outlined in the Japanese Pediatric Guideline for the Treatment and Management of Bronchial Asthma 2020. Statistical differences were calculated using univariate analyses (chi-square or Mann‒Whitney U test).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We enrolled 203 children hospitalized for asthma attacks and collected nasopharyngeal samples from 189 patients. The median patient age was 3.0 years. Asthma severity was classified as mild (4.0%), moderate (82.3%), or severe (13.8%). The proportion of viral respiratory infections was 95.2% (180/189). The rate of patients with multiple viral infections was 20.6% (39/189). The most frequently detected pathogens were rhinovirus and enterovirus (RV/EV) at 69.3% (131/189), allowing for duplicate detection, followed by respiratory syncytial virus (RSV) at 28.6% (54/189). We also detected RV/EV almost every month compared to RSV and other viruses. In addition, RV/EV-positive patients were significantly older (p = 0.033), exhibited higher WBC counts (p &lt; 0.001) and higher Eos counts (p &lt; 0.001), had elevated total IgE levels (p &lt; 0.001) and house dust mite-specific IgE levels (p = 0.019), had a shorter duration of hospitalization (p &lt; 0.001), and had a shorter duration of oxygen therapy (p &lt; 0.001). In patients positive for RV/EV, the use of ICSs significantly reduced the severity of the condition (p &lt; 0.001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Even under strict infection control measures, respiratory viruses were detected in the nasopharynx of almost all paediatric patients who had asthma exacerbations requiring hospitalization.</AbstractText><CopyrightInformation>© 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sasada</LastName><ForeName>Tsuyoshi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Kobe City Medical Center General Hospital, 1-1, Minatojima-Minamimachi 2-Chome, Chuo-Ku, Kobe, 650-0047, Japan. tsuyoshisasada63@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayashi</LastName><ForeName>Ken</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Kobe City Medical Center General Hospital, 1-1, Minatojima-Minamimachi 2-Chome, Chuo-Ku, Kobe, 650-0047, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okafuji</LastName><ForeName>Ikuo</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Kobe City Medical Center General Hospital, 1-1, Minatojima-Minamimachi 2-Chome, Chuo-Ku, Kobe, 650-0047, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miyakoshi</LastName><ForeName>Chisato</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Kobe City Medical Center General Hospital, 1-1, Minatojima-Minamimachi 2-Chome, Chuo-Ku, Kobe, 650-0047, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsuruta</LastName><ForeName>Satoru</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Kobe City Medical Center General Hospital, 1-1, Minatojima-Minamimachi 2-Chome, Chuo-Ku, Kobe, 650-0047, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Pulm Med</MedlineTA><NlmUniqueID>100968563</NlmUniqueID><ISSNLinking>1471-2466</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>37341-29-0</RegistryNumber><NameOfSubstance UI="D007073">Immunoglobulin E</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="Y">Asthma</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="Y">Virus Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012136" MajorTopicYN="N">Respiratory Syncytial Viruses</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017053" MajorTopicYN="N">Infection Control</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007073" MajorTopicYN="N">Immunoglobulin E</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="N">Rhinovirus</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Asthma exacerbations</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Children</Keyword><Keyword MajorTopicYN="N">Enterovirus</Keyword><Keyword MajorTopicYN="N">Respiratory syncytial virus</Keyword><Keyword MajorTopicYN="N">Rhinovirus</Keyword><Keyword MajorTopicYN="N">Viral respiratory infections</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>1</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>30</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>29</Day><Hour>23</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38031001</ArticleId><ArticleId IdType="pmc">PMC10685531</ArticleId><ArticleId IdType="doi">10.1186/s12890-023-02779-9</ArticleId><ArticleId IdType="pii">10.1186/s12890-023-02779-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jartti T, Gern JE. Role of viral infections in the development and exacerbation of asthma in children. J Allergy Clin Immunol. 2017;140:895–906. doi: 10.1016/j.jaci.2017.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2017.08.003</ArticleId><ArticleId IdType="pmc">PMC7172811</ArticleId><ArticleId IdType="pubmed">28987219</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Garcia ML, Calvo Rey C, Del Rosal RT. Pediatric asthma and viral infection. Arch Bronconeumol. 2016;52:269–273. doi: 10.1016/j.arbres.2015.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arbres.2015.11.008</ArticleId><ArticleId IdType="pmc">PMC7105201</ArticleId><ArticleId IdType="pubmed">26766408</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson DJ, Lemanske RF., Jr The role of respiratory virus infections in childhood asthma inception. Immunol Allergy Clin North Am. 2010;30:513–522. doi: 10.1016/j.iac.2010.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.iac.2010.08.004</ArticleId><ArticleId IdType="pmc">PMC2966844</ArticleId><ArticleId IdType="pubmed">21029935</ArticleId></ArticleIdList></Reference><Reference><Citation>Holtzman MJ. Asthma as a chronic disease of the innate and adaptive immune systems responding to viruses and allergens. J Clin Invest. 2012;122:2741–2748. doi: 10.1172/JCI60325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI60325</ArticleId><ArticleId IdType="pmc">PMC3408734</ArticleId><ArticleId IdType="pubmed">22850884</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L, Symington P, O'Toole S, Myint SH, Tyrrell DA, et al. Community study of role of viral infections in exacerbations of asthma in 9–11 year old children. BMJ. 1995;310:1225–1229. doi: 10.1136/bmj.310.6989.1225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.310.6989.1225</ArticleId><ArticleId IdType="pmc">PMC2549614</ArticleId><ArticleId IdType="pubmed">7767192</ArticleId></ArticleIdList></Reference><Reference><Citation>Arden KE, Faux CE, O'Neill NT, McErlean P, Nitsche A, Lambert SB, Nissen MD, Sloots TP, Mackay IM. Molecular characterization and distinguishing features of a novel human rhinovirus (HRV) C, HRVC-QCE, detected in children with fever, cough and wheeze during 2003. J Clin Virol. 2010;47:219–223. doi: 10.1016/j.jcv.2010.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2010.01.001</ArticleId><ArticleId IdType="pmc">PMC7108254</ArticleId><ArticleId IdType="pubmed">20106717</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen DP, Vermeulen F, Debeer A, Lagrou K, Smits A. Impact of COVID-19 on viral respiratory infection epidemiology in young children: a single-center analysis. Front Public Health. 2022;10:931242. doi: 10.3389/fpubh.2022.931242.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.931242</ArticleId><ArticleId IdType="pmc">PMC9530989</ArticleId><ArticleId IdType="pubmed">36203684</ArticleId></ArticleIdList></Reference><Reference><Citation>Teo KW, Patel D, Sisodia S, Roland D, Gaillard EA, Tang JW. Rhinovirus persistence during the COVID-19 pandemic - impact on pediatric acute wheezing presentations. J Med Virol. 2022;94:5547–5552. doi: 10.1002/jmv.27986.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27986</ArticleId><ArticleId IdType="pmc">PMC9350342</ArticleId><ArticleId IdType="pubmed">35811371</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z, Wang X, Wan XG, Wang ML, Qiu ZH, Chen JL, Shi MH, Zhang SY, Xia YL. Pediatric asthma control during the COVID-19 pandemic: a systematic review and meta-analysis. Pediatr Pulmonol. 2022;57:20–25. doi: 10.1002/ppul.25736.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.25736</ArticleId><ArticleId IdType="pmc">PMC8662014</ArticleId><ArticleId IdType="pubmed">34672436</ArticleId></ArticleIdList></Reference><Reference><Citation>Kouis P, Lemonaris M, Xenophontos E, Panayiotou A, Yiallouros PK. The impact of COVID-19 lockdown measures on symptoms control in children with asthma: A systematic review and meta-analysis of observational cohort studies. Pediatr Pulmonol. 2023 Aug 22. Online ahead of print</Citation><ArticleIdList><ArticleId IdType="pubmed">37606188</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadopoulos NG, Mathioudakis AG, Custovic A, Deschildre A, Phipatanakul W, Wong G, Xepapadaki P, Abou-Taam R, Agache I, Castro-Rodriguez JA, et al. Childhood asthma outcomes during the COVID-19 pandemic: findings from the PeARL multi-national cohort. Allergy. 2021;76:1765–1775. doi: 10.1111/all.14787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14787</ArticleId><ArticleId IdType="pmc">PMC8013557</ArticleId><ArticleId IdType="pubmed">33608919</ArticleId></ArticleIdList></Reference><Reference><Citation>Bun S, Kishimoto K, Shin JH, Maekawa T, Takada D, Morishita T, Kunisawa S, Imanaka Y. Impact of the COVID-19 pandemic on asthma exacerbations in children: a multi-center survey using an administrative database in Japan. Allergol Int. 2021;70:489–491. doi: 10.1016/j.alit.2021.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.alit.2021.06.001</ArticleId><ArticleId IdType="pmc">PMC8282991</ArticleId><ArticleId IdType="pubmed">34281768</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan HF, He CH, Yin GQ, Qin Y, Jiang N, Lu G, Li X. Frequency of asthma exacerbation in children during the coronavirus disease pandemic with strict mitigative countermeasures. Pediatr Pulmonol. 2021;56:1455–1463. doi: 10.1002/ppul.25335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.25335</ArticleId><ArticleId IdType="pubmed">33684257</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreger JE, Hershenson MB. Effects of COVID-19 and social distancing on rhinovirus infections and asthma exacerbations. Viruses. 2022;14:2340. doi: 10.3390/v14112340.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14112340</ArticleId><ArticleId IdType="pmc">PMC9698629</ArticleId><ArticleId IdType="pubmed">36366439</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuitunen I, Artama M, Haapanen M, Renko M. Rhinovirus spread in children during the COVID-19 pandemic despite social restrictions - a nationwide register study in Finland. J Med Virol. 2021;93:6063–6067. doi: 10.1002/jmv.27180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27180</ArticleId><ArticleId IdType="pmc">PMC8426983</ArticleId><ArticleId IdType="pubmed">34228369</ArticleId></ArticleIdList></Reference><Reference><Citation>Varela FH, Sartor ITS, Polese-Bonatto M, Azevedo TR, Kern LB, Fazolo T, de David CN, Zavaglia GO, Fernandes IR, Krauser JRM, et al. Rhinovirus as the main co-circulating virus during the COVID-19 pandemic in children. J Pediatr (Rio J) 2022;98:579–586. doi: 10.1016/j.jped.2022.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jped.2022.03.003</ArticleId><ArticleId IdType="pmc">PMC9015957</ArticleId><ArticleId IdType="pubmed">35490727</ArticleId></ArticleIdList></Reference><Reference><Citation>City of Kobe: COVID-19. https://www.city.kobe.lg.jp/a73576/kenko/health/infection/protection/coronavirus.html; 2023. Accessed 10 Oct 2023.</Citation></Reference><Reference><Citation>Shimojo N. Japanese pediatric guideline for the treatment and management of asthma 2020 (JPGL2020) Arerugi. 2021;70:925–930.</Citation><ArticleIdList><ArticleId IdType="pubmed">34588350</ArticleId></ArticleIdList></Reference><Reference><Citation>Eckbo EJ, Locher K, Caza M, Li L, Lavergne V, Charles M. Evaluation of the BioFire® COVID-19 test and Respiratory Panel 2.1 for rapid identification of SARS-CoV-2 in nasopharyngeal swab samples. Diagn Microbiol Infect Dis. 2021;99:115260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7654322</ArticleId><ArticleId IdType="pubmed">33340934</ArticleId></ArticleIdList></Reference><Reference><Citation>Berry GJ, Zhen W, Smith E, Manji R, Silbert S, Lima A, Harington A, McKinley K, Kensinger B, Neff C, et al. Multicenter evaluation of the BioFire respiratory Panel 2.1 (RP2.1) for detection of SARS-CoV-2 in nasopharyngeal swab samples. J Clin Microbiol. 2022;60:e0006622.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9116161</ArticleId><ArticleId IdType="pubmed">35387475</ArticleId></ArticleIdList></Reference><Reference><Citation>Oermann CM, Schuster JE, Conners GP, Newland JG, Selvarangan R, Jackson MA. Enterovirus d68. A focused review and clinical highlights from the 2014 U.S. outbreak. Ann Am Thorac Soc. 2015;12:775–781.</Citation><ArticleIdList><ArticleId IdType="pubmed">25714788</ArticleId></ArticleIdList></Reference><Reference><Citation>Brotons P, Jordan I, Bassat Q, Henares D, Fernandez de Sevilla M, Ajanovic S, Redin A, Fumado V, Baro B, Claverol J, et al. The positive rhinovirus/enterovirus detection and SARS-CoV-2 persistence beyond the acute infection phase: an intra-household surveillance study. Viruses. 2021;13:1598.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8402816</ArticleId><ArticleId IdType="pubmed">34452462</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ. 1993;307:982–986. doi: 10.1136/bmj.307.6910.982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.307.6910.982</ArticleId><ArticleId IdType="pmc">PMC1679193</ArticleId><ArticleId IdType="pubmed">8241910</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng XY, Xu YJ, Guan WJ, Lin LF. Regional, age and respiratory-secretion-specific prevalence of respiratory viruses associated with asthma exacerbation: a literature review. Arch Virol. 2018;163:845–853. doi: 10.1007/s00705-017-3700-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-017-3700-y</ArticleId><ArticleId IdType="pmc">PMC7087223</ArticleId><ArticleId IdType="pubmed">29327237</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishima S, Chisaka H, Fujiwara T, Furusho K, Hayashi S, Hiraba K, Kanaya M, Kobayashi N, Kuda N, Kumamoto T, et al. Surveys on the prevalence of pediatric bronchial asthma in Japan: a comparison between the 1982, 1992, and 2002 surveys conducted in the same region using the same methodology. Allergol Int. 2009;58:37–53. doi: 10.2332/allergolint.O-08-550.</Citation><ArticleIdList><ArticleId IdType="doi">10.2332/allergolint.O-08-550</ArticleId><ArticleId IdType="pubmed">19050372</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe N, Yasudo H, Fukano R, Nakamura T, Okada S, Wakiguchi H, Okazaki F, Shirabe K, Toda S, Okamoto R, et al. Multi-season analyses of causative pathogens in children hospitalized with asthma exacerbation. Pediatr Allergy Immunol. 2019;30:724–731. doi: 10.1111/pai.13102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pai.13102</ArticleId><ArticleId IdType="pmc">PMC7167852</ArticleId><ArticleId IdType="pubmed">31251831</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahanchian H, Jones CM, Chen YS, Sly PD. Respiratory viral infections in children with asthma: do they matter and can we prevent them? BMC Pediatr. 2012;12:147. doi: 10.1186/1471-2431-12-147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2431-12-147</ArticleId><ArticleId IdType="pmc">PMC3471019</ArticleId><ArticleId IdType="pubmed">22974166</ArticleId></ArticleIdList></Reference><Reference><Citation>Xepapadaki P, Papadopoulos NG. Childhood asthma and infection: virus-induced exacerbations as determinants and modifiers. Eur Respir J. 2010;36:438–445. doi: 10.1183/09031936.00149009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00149009</ArticleId><ArticleId IdType="pubmed">20675781</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlsen KH. Asthma in olympians. Paediatr Respir Rev. 2016;17:34–35.</Citation><ArticleIdList><ArticleId IdType="pubmed">26631837</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamazaki S, Shima M, Yoda Y, Oka K, Kurosaka F, Shimizu S, Takahashi H, Nakatani Y, Nishikawa J, Fujiwara K, et al. Association between PM2.5 and primary care visits due to asthma attack in Japan: relation to Beijing's air pollution episode in January 2013. Environ Health Prev Med. 2014;19:172–176.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3944030</ArticleId><ArticleId IdType="pubmed">24343755</ArticleId></ArticleIdList></Reference><Reference><Citation>Johns DO, Linn WS. A review of controlled human SO2 exposure studies contributing to the US EPA integrated science assessment for sulfur oxides. Toxicologist. 2011;23:33–43.</Citation><ArticleIdList><ArticleId IdType="pubmed">21222560</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamaguchi H, Nozu K, Ishiko S, Kondo A, Ninchoji T, Nagano C, Takeda H, Unzaki A, Ishibashi K, Morioka I, et al. Impact of the state of emergency during the COVID-19 pandemic in 2020 on asthma exacerbations among children in Kobe City, Japan. Int J Environ Res Public Health. 2021;18:11407. doi: 10.3390/ijerph182111407.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph182111407</ArticleId><ArticleId IdType="pmc">PMC8583023</ArticleId><ArticleId IdType="pubmed">34769923</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu M, Chen Z, Cui H, Wang T, Zhang C, Yun K. Air pollution and critical air pollutant assessment during and after COVID-19 lockdowns: evidence from pandemic hotspots in China, the Republic of Korea, Japan, and India. Atmos Pollut Res. 2021;12:316–329. doi: 10.1016/j.apr.2020.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apr.2020.11.013</ArticleId><ArticleId IdType="pmc">PMC7695571</ArticleId><ArticleId IdType="pubmed">33281465</ArticleId></ArticleIdList></Reference><Reference><Citation>Rankin DA, Spieker AJ, Perez A, Stahl AL, Rahman HK, Stewart LS, Schuster JE, Lively JY, Haddadin Z, Probst V, et al. Circulation of rhinoviruses and/or enteroviruses in pediatric patients with acute respiratory illness before and during the COVID-19 pandemic in the US. JAMA Netw Open. 2023;6:e2254909. doi: 10.1001/jamanetworkopen.2022.54909.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.54909</ArticleId><ArticleId IdType="pmc">PMC10408278</ArticleId><ArticleId IdType="pubmed">36749589</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institution of Infectious Disease. RSV infection cases reported per sentinel weekly. https://www.niid.go.jp/niid/ja/10/2096-weeklygraph/1661-21rsv.html2023. Accessed 10 Mar 2023.</Citation></Reference><Reference><Citation>Saravanos GL, Hu N, Homaira N, Muscatello DJ, Jaffe A, Bartlett AW, Wood NJ, Rawlinson W, Kesson A, Lingam R, et al. RSV epidemiology in Australia before and during COVID-19. Pediatrics. 2022;149:e2021053537. doi: 10.1542/peds.2021-053537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2021-053537</ArticleId><ArticleId IdType="pubmed">35083489</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakes GP, Arruda E, Ingram JM, Hoover GE, Zambrano JC, Hayden FG, Platts-Mills TA, Heymann PW. Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analyses. Am J Respir Crit Care Med. 1999;159:785–790.</Citation><ArticleIdList><ArticleId IdType="pubmed">10051251</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato M, Tsukagoshi H, Yoshizumi M, Saitoh M, Kozawa K, Yamada Y, Maruyama K, Hayashi Y, Kimura H. Different cytokine profile and eosinophil activation are involved in rhinovirus- and RS virus-induced acute exacerbation of childhood wheezing. Pediatr Allergy Immunol. 2011;22:e87–e94. doi: 10.1111/j.1399-3038.2010.01026.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-3038.2010.01026.x</ArticleId><ArticleId IdType="pubmed">20408969</ArticleId></ArticleIdList></Reference><Reference><Citation>Maspero J, Adir Y, Al-Ahmad M, Celis-Preciado CA, Colodenco FD, Giavina-Bianchi P, Lababidi H, Ledanois O, Mahoub B, Perng DW, et al. Type 2 inflammation in asthma and other airway diseases. ERJ Open Res. 2022;8:00576–2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9339769</ArticleId><ArticleId IdType="pubmed">35923421</ArticleId></ArticleIdList></Reference><Reference><Citation>Noor A, Fiorito T, Krilov LR. Cold weather viruses. Pediatr Rev. 2019;40:497–507. doi: 10.1542/pir.2018-0237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/pir.2018-0237</ArticleId><ArticleId IdType="pubmed">31575801</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan KF, Kwok WC, Ma TF, Hui CH, Tam TC, Wang JK, Ho JC, Lam DC, Sau-Man Ip M, Ho PL. Territory-wide study on hospital admissions for asthma exacerbations in the COVID-19 pandemic. Ann Am Thorac Soc. 2021;18:1624–33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8522301</ArticleId><ArticleId IdType="pubmed">33636091</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>